[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2012105814A3 - 개선된 플루오르-18 표지를 위한 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염 - Google Patents

개선된 플루오르-18 표지를 위한 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염 Download PDF

Info

Publication number
WO2012105814A3
WO2012105814A3 PCT/KR2012/000790 KR2012000790W WO2012105814A3 WO 2012105814 A3 WO2012105814 A3 WO 2012105814A3 KR 2012000790 W KR2012000790 W KR 2012000790W WO 2012105814 A3 WO2012105814 A3 WO 2012105814A3
Authority
WO
WIPO (PCT)
Prior art keywords
labeling
triazanonane
derivative
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
PCT/KR2012/000790
Other languages
English (en)
French (fr)
Other versions
WO2012105814A2 (ko
Inventor
정재민
셰티디네쉬
이동수
정준기
이명철
Original Assignee
서울대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교 산학협력단 filed Critical 서울대학교 산학협력단
Priority to US13/983,053 priority Critical patent/US9012604B2/en
Publication of WO2012105814A2 publication Critical patent/WO2012105814A2/ko
Publication of WO2012105814A3 publication Critical patent/WO2012105814A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 하기 화학식 1로 표시되는 트리아자노난 유도체, 또는 이의 약학 적으로 허용가능한 염 및 이의 제조방법에 관한 것으로, 본 발명에 따른 트리아자 노난 유도체는 금속-플루오라이드와 착체를 형성하여 F-18을 표지할 때 표지효율을 78~90%까지 높이는 효과를 나타냄으로써, 다양한 방사성 의약품 표지에 널리 이용 될 수 있다. [화학식 1] (상기 화학식 1에서, R1, R2, A. E. X, n 및 m은 본 명세서에서 정의한 바와 같다.)
PCT/KR2012/000790 2011-02-01 2012-02-01 개선된 플루오르-18 표지를 위한 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염 WO2012105814A2 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/983,053 US9012604B2 (en) 2011-02-01 2012-02-01 Triazanonane derivatives or pharmaceutically acceptable salt thereof for enhanced fluorine-18 labeling

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0010202 2011-02-01
KR1020110010202A KR101142153B1 (ko) 2011-02-01 2011-02-01 개선된 플루오르-18 표지를 위한 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염

Publications (2)

Publication Number Publication Date
WO2012105814A2 WO2012105814A2 (ko) 2012-08-09
WO2012105814A3 true WO2012105814A3 (ko) 2012-11-01

Family

ID=46271468

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/000790 WO2012105814A2 (ko) 2011-02-01 2012-02-01 개선된 플루오르-18 표지를 위한 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염

Country Status (3)

Country Link
US (1) US9012604B2 (ko)
KR (1) KR101142153B1 (ko)
WO (1) WO2012105814A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8545809B2 (en) 2007-01-11 2013-10-01 Immunomedics, Inc. Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
CA2814953A1 (en) * 2010-12-13 2012-06-21 Immunomedics, Inc. Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
CN103787998B (zh) * 2014-02-25 2015-09-23 江苏省原子医学研究所 一种双功能螯合剂p-SCN-NODA的合成方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050120494A1 (en) * 2003-09-26 2005-06-09 Laurent Vidal Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres
WO2009079024A1 (en) * 2007-12-19 2009-06-25 Immunomedics, Inc. Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules
US20090246130A1 (en) * 2007-01-11 2009-10-01 Immunomedics, Inc. Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563433B2 (en) 2007-01-11 2009-07-21 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
US7993626B2 (en) 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
CN103372221B (zh) 2007-01-11 2016-08-24 免疫医学股份有限公司 用于蛋白质、肽和其他分子的改进的f-18标记的方法和组合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050120494A1 (en) * 2003-09-26 2005-06-09 Laurent Vidal Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres
US20090246130A1 (en) * 2007-01-11 2009-10-01 Immunomedics, Inc. Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules
WO2009079024A1 (en) * 2007-12-19 2009-06-25 Immunomedics, Inc. Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DINESH SHETTY ET AL.: "Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18F-labling study", CHEMICAL COMMUNICATIONS, vol. 47, no. 34, 14 September 2011 (2011-09-14), pages 9732 - 9734 *
SHUANG LIU: "Radiolabeled Cyclic RGD Peptides as Integrin uvp3-Targeted Radiotracers:MaximizingBindingAffmityviaBivalency", BIOCONJUGATE CHEMISTRY, vol. 20, no. 12, 2009, pages 2199 - 2213 *

Also Published As

Publication number Publication date
US20130317196A1 (en) 2013-11-28
WO2012105814A2 (ko) 2012-08-09
KR101142153B1 (ko) 2012-05-10
US9012604B2 (en) 2015-04-21

Similar Documents

Publication Publication Date Title
IL223951A0 (en) (2-aryloxy- acetylamino) phenyl-propionic acid derivatives, method for producing same and use thereof as pharmaceuticals
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
TN2013000411A1 (en) Branched 3-phenylpropionic acid derivatives and the use thereof
RS60310B1 (sr) Ciklični derivati estra boronske kiseline, postupak za pripremu injihove terapeutske upotrebe
WO2012019426A8 (zh) 酞嗪酮类衍生物、其制备方法及其在医药上的应用
MX2016006336A (es) Compuestos pirazolopirimidina.
MY156938A (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
ZA201301463B (en) Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same
IL249826A0 (en) Propionic acid derivatives converted in 3-heteroylamino and their use in pharmaceutical preparations
IL230126A0 (en) Propionic acid derivatives substituted with heteroaroylamino in position 3 and their use as pharmaceuticals
HK1218709A1 (zh) 新水楊酸衍生物、其藥學上可接受的鹽、其組合物以及其使用方法
WO2012097116A3 (en) Isotopologues of isoindole derivatives
ZA201400188B (en) Substituted cinnamamide derivative, preparation method and use thereof
UA118562C2 (uk) Модулятори рецептора cxcr7
WO2012105814A3 (ko) 개선된 플루오르-18 표지를 위한 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염
EP2759547A4 (en) PLATIN CONNECTION WITH AMINO OR ALKYLAMINE-CONTAINING AMMONIC ACID DERIVATIVES AS A SUBSTITUTE GROUP, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF
EP2742946A4 (en) PROCESS FOR THE PRODUCTION OF PYROSTEGIA VENUSTA DERIVATIVES, PYROSTEGIA VENUSTA DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
WO2014009204A8 (de) Oxasilacyclen und verfahren zu deren herstellung
WO2012150607A3 (en) Oral liquid composition comprising divalproex sodium and process for preparing thereof
PL399613A1 (pl) Pochodne estrów diarylowych kwasów 1-aminoalkanofosfonowych, sposób wytwarzania pochodnych estrów diarylowych kwasów 1-aminoalkanofosfonowych oraz ich zastosowanie
IL233172A0 (en) Derivatives of 3,1-diphenylpropane, preparations containing them and their use
JO3276B1 (ar) طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا.
PL393268A1 (pl) Kwas 2-amino-6-dihydroksyborylo-1,2,3,4-tetrahydronaftaleno-2-karboksylowy i sposób jego wytwarzania
EA201400882A1 (ru) Способ стереоселективного синтеза 9-гидрокси-5-оксо-1,4-диазаспиро[5.5]ундеканов, содержащих защитные группы в 1,4-положениях

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12742678

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13983053

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12742678

Country of ref document: EP

Kind code of ref document: A2